Suzanne E Pertsch, MD
Internal Medicine · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations
Hospitals listed: 058123 · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pertsch’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G64384 · Current
Licensed to practise in California · since 1988 · expires 2026-09-30 · Brown University Program in Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$17,412
Medicare paid this office $17,412 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 30 | $6,077 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $2,171 | $155 |
| Return visit (30+ min) | 22 | $2,032 | $85 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $852 | $29 |
| Short return visit (20+ min) | 15 | $848 | $57 |
See all 6 services
| Long return visit (40+ min) | 30 | $6,077 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $2,171 | $155 |
| Return visit (30+ min) | 22 | $2,032 | $85 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $852 | $29 |
| Short return visit (20+ min) | 15 | $848 | $57 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 20 | $385 | $15 |
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 79 · Women 71% · Health risk score 1.31. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 59% · Chronic kidney disease 30% · Atrial fibrillation 27% · Diabetes 21% · Coronary heart disease 21% · COPD 21% · Heart failure 20% · Cancer 20% · Depression 20%.
The office billed $55,959, Medicare allowed $23,496 and paid $17,412; for 198 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 198 | 79 | 1.31 | $55,959 | $17,412 |
| 2023 | 200 | 357 | 76 | 0.87 | $101,151 | $39,747 |
| 2022 | 143 | 312 | 75 | 0.80 | $72,473 | $32,160 |
| 2021 | 81 | 153 | 75 | 0.85 | $33,969 | $16,677 |
| 2020 | 80 | 145 | 74 | 0.89 | $28,203 | $13,398 |
| 2019 | 86 | 205 | 75 | 0.96 | $41,246 | $17,569 |
| 2018 | 110 | 209 | 75 | 1.06 | $45,135 | $16,289 |
| 2017 | 134 | 222 | 76 | 1.02 | $46,613 | $16,096 |
| 2016 | 78 | 232 | 76 | 1.28 | $52,752 | $20,465 |
| 2015 | 113 | 241 | 78 | 1.63 | $48,169 | $20,650 |
| 2014 | 249 | 711 | 78 | 1.57 | $137,623 | $69,533 |
| 2013 | 306 | 849 | 79 | 1.74 | $169,372 | $76,048 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,391 | $157 |
| Long return visit (40+ min) | 44 | $8,298 | $146 |
| Return visit (30+ min) | 68 | $7,733 | $107 |
| Short return visit (20+ min) | 66 | $5,092 | $70 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 16 | $1,213 | $76 |
| Administration of influenza virus vaccine | 16 | $594 | $37 |
| Administration of pneumococcal vaccine | 12 | $421 | $35 |
2022: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $9,070 | $156 |
| Return visit (30+ min) | 49 | $6,667 | $108 |
| Long return visit (40+ min) | 29 | $5,232 | $159 |
| Short return visit (20+ min) | 52 | $5,005 | $77 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 20 | $1,405 | $70 |
| Administration of influenza virus vaccine | 22 | $805 | $37 |
| Short return visit | 15 | $736 | $49 |
2021: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,408 | $146 |
| Return visit (30+ min) | 21 | $2,773 | $103 |
| Long return visit (40+ min) | 11 | $2,091 | $149 |
| Short return visit (20+ min) | 21 | $1,603 | $73 |
2020: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,512 | $141 |
| Short return visit (20+ min) | 32 | $2,562 | $73 |
| Return visit (30+ min) | 22 | $2,444 | $94 |
2019: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,585 | $140 |
| Return visit (30+ min) | 27 | $3,772 | $97 |
| Short return visit (20+ min) | 52 | $2,990 | $53 |
| Influenza vaccine split virus, preservative free | 11 | $584 | $53 |
| Administration of pneumococcal vaccine | 13 | $267 | $21 |
| Administration of influenza virus vaccine | 11 | $226 | $21 |
2018: 3 services
| Short return visit (20+ min) | 74 | $4,308 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,808 | $131 |
| Return visit (30+ min) | 26 | $2,826 | $79 |
2017: 3 services
| Return visit (30+ min) | 43 | $4,708 | $87 |
| Short return visit (20+ min) | 78 | $4,254 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,695 | $127 |
2016: 6 services
| Return visit (30+ min) | 36 | $4,811 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $3,902 | $126 |
| Pneumococcal vaccine, 13-valent | 13 | $2,252 | $173 |
| Short return visit (20+ min) | 28 | $2,019 | $63 |
| Advance care planning, first 30 minutes | 15 | $1,374 | $76 |
| Administration of pneumococcal vaccine | 15 | $486 | $30 |
2015: 6 services
| Pneumococcal vaccine, 13-valent | 23 | $3,528 | $153 |
| Return visit (30+ min) | 40 | $3,517 | $76 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,074 | $134 |
| Short return visit (20+ min) | 49 | $2,737 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,445 | $188 |
| Administration of pneumococcal vaccine | 25 | $760 | $30 |
2014: 9 services
| Return visit (30+ min) | 122 | $18,465 | $89 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 79 | $15,708 | $199 |
| Short return visit (20+ min) | 145 | $12,213 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,327 | $179 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,425 | $136 |
| Long return visit (40+ min) | 13 | $2,114 | $111 |
| Pneumococcal vaccine, 23-valent | 14 | $1,068 | $76 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $769 | $45 |
| Administration of pneumococcal vaccine | 12 | $378 | $31 |
2013: 9 services
| Return visit (30+ min) | 109 | $18,783 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,035 | $167 |
| Short return visit (20+ min) | 109 | $12,487 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $7,259 | $127 |
| Long return visit (40+ min) | 43 | $5,699 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,302 | $86 |
| Extended inpatient or observation hospital service, first hour | 24 | $2,133 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,475 | $113 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $772 | $32 |
Medicaid work
$2,117 in 2024
Medicaid paid $2,117 for 169 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 157 | $2,117 |
| Return visit (30+ min) | 12 | $0 |
| 2024 | 169 | 2 | 20 | $2,117 |
| 2023 | 28 | 1 | 14 | $283 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 28 | $283 |
Drugs they prescribed that Part D paid
$234,881
Pharmacies billed $234,881 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (39 of 2,352) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,040 generic and fewer than 11 brand-name prescriptions · $234,881 in drug cost · 83 antibiotic prescriptions to 45 people · 32 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 33 | $41,351 | $1,253 |
| Xarelto | 20 | $15,148 | $757 |
| Trelegy Ellipta | 12 | $7,699 | $642 |
| Atrovent Hfa | 12 | $6,444 | $537 |
| Atorvastatin | 197 | $4,044 | $21 |
See all 57 drugs
| Eliquis | 33 | $41,351 | $1,253 |
| Xarelto | 20 | $15,148 | $757 |
| Trelegy Ellipta | 12 | $7,699 | $642 |
| Atrovent Hfa | 12 | $6,444 | $537 |
| Atorvastatin | 197 | $4,044 | $21 |
| Albuterol Sulfate Hfa | 38 | $2,037 | $54 |
| Mirtazapine | 55 | $1,913 | $35 |
| Pantoprazole | 32 | $1,394 | $44 |
| Levothyroxine | 98 | $1,148 | $12 |
| Montelukast | 22 | $1,130 | $51 |
| Gabapentin | 89 | $1,118 | $13 |
| Sertraline | 50 | $1,076 | $22 |
| Amlodipine Besylate | 90 | $1,075 | $12 |
| Omeprazole | 41 | $982 | $24 |
| Losartan | 57 | $787 | $14 |
| Finasteride | 16 | $731 | $46 |
| Tamsulosin | 15 | $730 | $49 |
| Azelastine | 14 | $662 | $47 |
| Duloxetine | 14 | $653 | $47 |
| Ibandronate | 14 | $568 | $41 |
| Clobetasol Propionate | 11 | $513 | $47 |
| Trazodone | 39 | $416 | $11 |
| Methylphenidate | 11 | $374 | $34 |
| Omega-3 Acid Ethyl Esters | 31 | $354 | $11 |
| Metformin Hcl Er | 19 | $353 | $19 |
| Buspirone | 15 | $320 | $21 |
| Losartan-Hydrochlorothiazide | 13 | $308 | $24 |
| Metformin | 30 | $307 | $10 |
| Nystop | 12 | $295 | $25 |
| Metoprolol | 22 | $291 | $13 |
| Simvastatin | 19 | $289 | $15 |
| Amitriptyline | 16 | $289 | $18 |
| Lisinopril | 41 | $262 | $6 |
| Propranolol | 16 | $258 | $16 |
| Escitalopram | 23 | $242 | $11 |
| Fluoxetine | 11 | $216 | $20 |
| Allopurinol | 14 | $215 | $15 |
| Alendronate | 32 | $215 | $7 |
| Citalopram Hbr | 41 | $200 | $5 |
| Hydroxyzine | 12 | $193 | $16 |
| Benazepril | 11 | $185 | $17 |
| Furosemide | 29 | $181 | $6 |
| Hydrochlorothiazide | 27 | $150 | $6 |
| Cyclobenzaprine | 25 | $150 | $6 |
| Clopidogrel | 14 | $127 | $9 |
| Triamterene-Hydrochlorothiazid | 15 | $125 | $8 |
| Azithromycin | 27 | $123 | $5 |
| Latanoprost | 15 | $114 | $8 |
| Quetiapine | 12 | $106 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $101 | $9 |
| Cephalexin | 16 | $90 | $6 |
| Lisinopril-Hydrochlorothiazide | 16 | $88 | $5 |
| Valacyclovir | 12 | $85 | $7 |
| Spironolactone | 13 | $65 | $5 |
| Prednisone | 20 | $60 | $3 |
| Lorazepam | 22 | $53 | $2 |
| Hydrocodone-Acetaminophen | 11 | $50 | $5 |
Year by year
| 2024 | 2,352 | 282 | 2% (39) | None | $234,881 |
| 2023 | 1,447 | 198 | 3% (45) | 12% | $81,668 |
| 2022 | 1,048 | 125 | 4% (37) | None | $54,699 |
| 2021 | 923 | 96 | 4% (41) | None | $48,355 |
| 2020 | 880 | 92 | 4% (32) | None | $53,878 |
| 2019 | 621 | 74 | None | 16% | $48,142 |
| 2018 | 653 | 75 | 3% (16) | 15% | $44,076 |
| 2017 | 738 | 79 | 3% (19) | 21% | $49,065 |
| 2016 | 732 | 106 | 2% (15) | 17% | $33,422 |
| 2015 | 1,717 | 182 | 2% (29) | None | $108,211 |
| 2014 | 2,724 | 229 | 5% (125) | 20% | $182,393 |
| 2013 | 2,332 | 193 | 4% (103) | 24% | $141,276 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Eliquis | 20 | $22,594 | $1,130 |
| Mirtazapine | 31 | $2,082 | $67 |
| Atorvastatin | 142 | $1,895 | $13 |
| Synthroid | 16 | $1,484 | $93 |
| Levothyroxine | 97 | $1,403 | $14 |
| Hydrocodone-Acetaminophen | 35 | $1,086 | $31 |
| Sumatriptan | 23 | $932 | $41 |
| Albuterol Sulfate Hfa | 33 | $909 | $28 |
| Losartan | 57 | $829 | $15 |
| Amlodipine Besylate | 61 | $808 | $13 |
| Duloxetine | 14 | $598 | $43 |
| Pantoprazole | 15 | $581 | $39 |
| Omeprazole | 31 | $543 | $18 |
| Gabapentin | 52 | $537 | $10 |
| Escitalopram | 33 | $442 | $13 |
| Sertraline | 16 | $421 | $26 |
| Montelukast | 22 | $407 | $18 |
| Metoprolol | 11 | $399 | $36 |
| Alendronate | 29 | $335 | $12 |
| Losartan-Hydrochlorothiazide | 18 | $252 | $14 |
| Citalopram Hbr | 31 | $235 | $8 |
| Lisinopril | 28 | $223 | $8 |
| Rosuvastatin | 15 | $199 | $13 |
| Nitrofurantoin Mono-Macro | 12 | $166 | $14 |
| Hydrochlorothiazide | 23 | $129 | $6 |
| Triamterene-Hydrochlorothiazid | 11 | $129 | $12 |
| Azithromycin | 18 | $120 | $7 |
| Paxlovid (Eua) | 11 | $120 | $11 |
| Fluconazole | 15 | $118 | $8 |
| Omega-3 Acid Ethyl Esters | 12 | $107 | $9 |
| Cyclobenzaprine | 19 | $95 | $5 |
| Simvastatin | 12 | $92 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $90 | $8 |
| Cephalexin | 16 | $80 | $5 |
| Lorazepam | 12 | $30 | $2 |
2022: 27 drugs
| Eliquis | 16 | $14,103 | $881 |
| Mirtazapine | 19 | $1,815 | $96 |
| Atorvastatin | 117 | $1,668 | $14 |
| Levothyroxine | 90 | $1,455 | $16 |
| Duloxetine | 19 | $1,285 | $68 |
| Hydrocodone-Acetaminophen | 27 | $981 | $36 |
| Losartan | 47 | $629 | $13 |
| Gabapentin | 38 | $524 | $14 |
| Escitalopram | 24 | $459 | $19 |
| Losartan-Hydrochlorothiazide | 23 | $454 | $20 |
| Propranolol | 11 | $429 | $39 |
| Amlodipine Besylate | 40 | $348 | $9 |
| Montelukast | 21 | $334 | $16 |
| Albuterol Sulfate Hfa | 12 | $331 | $28 |
| Sumatriptan | 23 | $267 | $12 |
| Omeprazole | 18 | $235 | $13 |
| Sertraline | 20 | $199 | $10 |
| Alendronate | 16 | $123 | $8 |
| Cyclobenzaprine | 21 | $105 | $5 |
| Lisinopril | 26 | $93 | $4 |
| Potassium Chloride | 12 | $80 | $7 |
| Fluconazole | 13 | $77 | $6 |
| Azithromycin | 11 | $71 | $6 |
| Furosemide | 17 | $62 | $4 |
| Lorazepam | 18 | $59 | $3 |
| Citalopram Hbr | 17 | $46 | $3 |
| Simvastatin | 11 | $44 | $4 |
2021: 25 drugs
| Eliquis | 16 | $10,504 | $657 |
| Levothyroxine | 85 | $1,832 | $22 |
| Mirtazapine | 16 | $1,518 | $95 |
| Atorvastatin | 91 | $1,273 | $14 |
| Sumatriptan | 28 | $946 | $34 |
| Losartan | 45 | $789 | $18 |
| Gabapentin | 23 | $590 | $26 |
| Metoprolol | 11 | $565 | $51 |
| Duloxetine | 12 | $529 | $44 |
| Hydrocodone-Acetaminophen | 23 | $517 | $22 |
| Losartan-Hydrochlorothiazide | 16 | $473 | $30 |
| Pantoprazole | 19 | $443 | $23 |
| Acetaminophen-Codeine | 11 | $295 | $27 |
| Montelukast | 13 | $292 | $22 |
| Amlodipine Besylate | 43 | $289 | $7 |
| Omeprazole | 15 | $288 | $19 |
| Trazodone | 11 | $226 | $21 |
| Sertraline | 19 | $216 | $11 |
| Alendronate | 17 | $163 | $10 |
| Citalopram Hbr | 21 | $122 | $6 |
| Simvastatin | 16 | $108 | $7 |
| Lisinopril | 22 | $101 | $5 |
| Potassium Chloride | 12 | $79 | $7 |
| Hydrochlorothiazide | 16 | $64 | $4 |
| Furosemide | 17 | $64 | $4 |
2020: 26 drugs
| Eliquis | 25 | $18,530 | $741 |
| Flovent Hfa | 12 | $2,917 | $243 |
| Levothyroxine | 70 | $1,862 | $27 |
| Metoprolol | 27 | $1,377 | $51 |
| Atorvastatin | 69 | $1,006 | $15 |
| Synthroid | 13 | $1,001 | $77 |
| Losartan | 36 | $680 | $19 |
| Losartan-Hydrochlorothiazide | 15 | $462 | $31 |
| Sumatriptan | 19 | $453 | $24 |
| Hydrocodone-Acetaminophen | 22 | $437 | $20 |
| Pantoprazole | 16 | $356 | $22 |
| Montelukast | 21 | $351 | $17 |
| Amlodipine Besylate | 38 | $350 | $9 |
| Trazodone | 13 | $335 | $26 |
| Gabapentin | 25 | $329 | $13 |
| Omeprazole | 12 | $286 | $24 |
| Butalbital-Acetaminophen-Caffe | 11 | $270 | $25 |
| Clopidogrel | 12 | $259 | $22 |
| Citalopram Hbr | 23 | $248 | $11 |
| Nitrofurantoin Mono-Macro | 12 | $153 | $13 |
| Simvastatin | 14 | $150 | $11 |
| Hydrochlorothiazide | 15 | $148 | $10 |
| Furosemide | 24 | $143 | $6 |
| Lisinopril | 15 | $131 | $9 |
| Sertraline | 15 | $125 | $8 |
| Potassium Chloride | 12 | $79 | $7 |
2019: 17 drugs
| Flovent Hfa | 13 | $3,034 | $233 |
| Levothyroxine | 56 | $1,479 | $26 |
| Metoprolol | 24 | $1,303 | $54 |
| Atorvastatin | 50 | $943 | $19 |
| Mirtazapine | 13 | $735 | $57 |
| Pantoprazole | 15 | $560 | $37 |
| Duloxetine | 13 | $496 | $38 |
| Amlodipine Besylate | 26 | $461 | $18 |
| Omeprazole | 11 | $439 | $40 |
| Losartan-Hydrochlorothiazide | 21 | $439 | $21 |
| Losartan | 22 | $437 | $20 |
| Gabapentin | 22 | $299 | $14 |
| Clopidogrel | 12 | $252 | $21 |
| Trazodone | 11 | $219 | $20 |
| Montelukast | 14 | $178 | $13 |
| Lisinopril | 12 | $135 | $11 |
| Citalopram Hbr | 15 | $131 | $9 |
2018: 22 drugs
| Advair Diskus | 12 | $4,994 | $416 |
| Estradiol | 18 | $1,420 | $79 |
| Levothyroxine | 48 | $1,335 | $28 |
| Mirtazapine | 17 | $1,225 | $72 |
| Metoprolol | 26 | $1,164 | $45 |
| Atorvastatin | 47 | $1,030 | $22 |
| Gabapentin | 28 | $574 | $20 |
| Fluoxetine | 15 | $548 | $37 |
| Omeprazole | 13 | $462 | $36 |
| Sumatriptan | 25 | $439 | $18 |
| Amlodipine Besylate | 17 | $398 | $23 |
| Duloxetine | 12 | $367 | $31 |
| Losartan-Hydrochlorothiazide | 22 | $358 | $16 |
| Clopidogrel | 14 | $252 | $18 |
| Paroxetine | 11 | $219 | $20 |
| Hydrocodone-Acetaminophen | 14 | $208 | $15 |
| Pantoprazole | 12 | $197 | $16 |
| Triamterene-Hydrochlorothiazid | 11 | $181 | $16 |
| Simvastatin | 13 | $177 | $14 |
| Lisinopril | 15 | $169 | $11 |
| Zolpidem | 13 | $144 | $11 |
| Diazepam | 11 | $110 | $10 |
2017: 25 drugs
| Advair Diskus | 15 | $6,715 | $448 |
| Janumet | 11 | $4,204 | $382 |
| Levothyroxine | 62 | $1,805 | $29 |
| Estradiol | 18 | $1,268 | $70 |
| Atorvastatin | 54 | $1,161 | $21 |
| Metoprolol | 22 | $1,018 | $46 |
| Mirtazapine | 11 | $827 | $75 |
| Fluoxetine | 14 | $643 | $46 |
| Amlodipine Besylate | 20 | $399 | $20 |
| Gabapentin | 17 | $368 | $22 |
| Sumatriptan | 16 | $340 | $21 |
| Divalproex | 14 | $242 | $17 |
| Hydrocodone-Acetaminophen | 16 | $235 | $15 |
| Losartan-Hydrochlorothiazide | 12 | $222 | $19 |
| Quetiapine | 13 | $213 | $16 |
| Montelukast | 14 | $213 | $15 |
| Alendronate | 23 | $191 | $8 |
| Triamterene-Hydrochlorothiazid | 11 | $171 | $16 |
| Lisinopril | 25 | $150 | $6 |
| Hydrochlorothiazide | 11 | $142 | $13 |
| Simvastatin | 14 | $115 | $8 |
| Atenolol | 12 | $104 | $9 |
| Citalopram Hbr | 14 | $101 | $7 |
| Donepezil | 12 | $94 | $8 |
| Azithromycin | 11 | $55 | $5 |
2016: 22 drugs
| Levothyroxine | 62 | $2,015 | $32 |
| Atorvastatin | 39 | $990 | $25 |
| Estradiol | 15 | $806 | $54 |
| Fluoxetine | 12 | $640 | $53 |
| Escitalopram | 21 | $593 | $28 |
| Bupropion Xl | 14 | $533 | $38 |
| Metoprolol | 12 | $527 | $44 |
| Sumatriptan | 16 | $515 | $32 |
| Montelukast | 13 | $298 | $23 |
| Amlodipine Besylate | 18 | $279 | $16 |
| Gabapentin | 22 | $270 | $12 |
| Simvastatin | 21 | $196 | $9 |
| Potassium Chloride | 12 | $161 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $154 | $14 |
| Citalopram Hbr | 27 | $137 | $5 |
| Losartan-Hydrochlorothiazide | 13 | $127 | $10 |
| Lisinopril | 18 | $124 | $7 |
| Alendronate | 21 | $122 | $6 |
| Hydrochlorothiazide | 13 | $113 | $9 |
| Atenolol | 16 | $106 | $7 |
| Azithromycin | 13 | $87 | $7 |
| Diazepam | 11 | $59 | $5 |
2015: 52 drugs
| Spiriva | 22 | $6,722 | $306 |
| Vesicare | 21 | $5,164 | $246 |
| Levothyroxine | 111 | $3,407 | $31 |
| Humalog | 13 | $2,696 | $207 |
| Estrace | 14 | $2,256 | $161 |
| Atorvastatin | 101 | $1,975 | $20 |
| Metoprolol | 35 | $1,706 | $49 |
| Lansoprazole | 19 | $1,528 | $80 |
| Duloxetine | 14 | $1,485 | $106 |
| Valsartan | 12 | $927 | $77 |
| Estradiol | 12 | $857 | $71 |
| Synthroid | 15 | $855 | $57 |
| Bupropion Xl | 24 | $855 | $36 |
| Potassium Chloride | 26 | $835 | $32 |
| Cartia Xt | 18 | $767 | $43 |
| Simvastatin | 64 | $690 | $11 |
| Omeprazole | 26 | $684 | $26 |
| Escitalopram | 43 | $679 | $16 |
| Triamterene-Hydrochlorothiazid | 30 | $603 | $20 |
| Enalapril Maleate | 12 | $577 | $48 |
| Zolpidem | 26 | $554 | $21 |
| Amlodipine Besylate | 57 | $529 | $9 |
| Amitriptyline | 20 | $418 | $21 |
| Montelukast | 21 | $401 | $19 |
| Spironolactone | 15 | $341 | $23 |
| Atenolol | 26 | $331 | $13 |
| Alendronate | 25 | $316 | $13 |
| Lisinopril | 53 | $312 | $6 |
| Hydrocodone-Acetaminophen | 12 | $295 | $25 |
| Fluticasone Propionate | 19 | $284 | $15 |
| Pramipexole Dihydrochloride | 18 | $263 | $15 |
| Sertraline | 28 | $240 | $9 |
| Venlafaxine Hcl Er | 11 | $231 | $21 |
| Losartan | 25 | $212 | $8 |
| Trazodone | 20 | $211 | $11 |
| Pantoprazole | 12 | $201 | $17 |
| Sumatriptan | 14 | $196 | $14 |
| Gabapentin | 22 | $194 | $9 |
| Citalopram Hbr | 38 | $188 | $5 |
| Mirtazapine | 18 | $183 | $10 |
| Metformin | 18 | $173 | $10 |
| Losartan-Hydrochlorothiazide | 18 | $169 | $9 |
| Quetiapine | 16 | $163 | $10 |
| Hydrochlorothiazide | 32 | $154 | $5 |
| Azithromycin | 24 | $151 | $6 |
| Carbidopa-Levodopa | 12 | $135 | $11 |
| Meloxicam | 12 | $101 | $8 |
| Nortriptyline | 13 | $97 | $7 |
| Alprazolam | 16 | $87 | $5 |
| Diazepam | 13 | $85 | $7 |
| Metoprolol | 13 | $69 | $5 |
| Furosemide | 13 | $36 | $3 |
2014: 74 drugs
| Vesicare | 26 | $7,059 | $271 |
| Spiriva | 24 | $6,925 | $289 |
| Lidocaine | 23 | $6,578 | $286 |
| Januvia | 14 | $4,721 | $337 |
| Celebrex | 13 | $4,649 | $358 |
| Estrace | 14 | $3,985 | $285 |
| Levothyroxine | 166 | $3,922 | $24 |
| Duloxetine | 16 | $3,774 | $236 |
| Diovan | 22 | $3,715 | $169 |
| Humalog | 16 | $2,862 | $179 |
| Premarin | 13 | $2,813 | $216 |
| Valsartan | 13 | $2,548 | $196 |
| Atorvastatin | 97 | $2,501 | $26 |
| Metoprolol | 47 | $2,347 | $50 |
| Zithromax | 12 | $1,884 | $157 |
| Synthroid | 32 | $1,706 | $53 |
| Methylphenidate | 29 | $1,660 | $57 |
| Escitalopram | 48 | $1,344 | $28 |
| Hydrocodone-Acetaminophen | 49 | $1,312 | $27 |
| Simvastatin | 98 | $1,127 | $12 |
| Liothyronine | 11 | $926 | $84 |
| Sumatriptan | 23 | $819 | $36 |
| Triamterene-Hydrochlorothiazid | 43 | $818 | $19 |
| Amlodipine Besylate | 75 | $813 | $11 |
| Montelukast | 18 | $800 | $44 |
| Omeprazole | 33 | $769 | $23 |
| Quetiapine | 39 | $692 | $18 |
| Fluoxetine | 24 | $597 | $25 |
| Spironolactone | 24 | $591 | $25 |
| Potassium Chloride | 20 | $571 | $29 |
| Pramipexole Dihydrochloride | 31 | $495 | $16 |
| Lisinopril | 67 | $480 | $7 |
| Citalopram Hbr | 54 | $467 | $9 |
| Azithromycin | 44 | $460 | $10 |
| Lorazepam | 41 | $455 | $11 |
| Diltiazem Er | 16 | $451 | $28 |
| Carisoprodol | 12 | $447 | $37 |
| Losartan | 26 | $447 | $17 |
| Bupropion Xl | 11 | $428 | $39 |
| Estradiol | 11 | $424 | $39 |
| Cartia Xt | 16 | $420 | $26 |
| Topiramate | 21 | $391 | $19 |
| Alprazolam | 46 | $380 | $8 |
| Atenolol | 20 | $361 | $18 |
| Pantoprazole | 25 | $353 | $14 |
| Zolpidem | 53 | $350 | $7 |
| Torsemide | 16 | $347 | $22 |
| Metformin | 30 | $341 | $11 |
| Fluticasone Propionate | 28 | $335 | $12 |
| Nitrofurantoin Mono-Macro | 18 | $326 | $18 |
| Sertraline | 31 | $315 | $10 |
| Losartan-Hydrochlorothiazide | 17 | $299 | $18 |
| Donepezil | 25 | $294 | $12 |
| Enalapril Maleate | 15 | $286 | $19 |
| Gabapentin | 30 | $275 | $9 |
| Mirtazapine | 26 | $272 | $10 |
| Clopidogrel | 18 | $255 | $14 |
| Methadone | 37 | $250 | $7 |
| Alendronate | 14 | $248 | $18 |
| Trazodone | 17 | $185 | $11 |
| Hydrochlorothiazide | 37 | $182 | $5 |
| Diazepam | 26 | $179 | $7 |
| Carbidopa-Levodopa | 12 | $177 | $15 |
| Allopurinol | 22 | $169 | $8 |
| Metoprolol | 25 | $153 | $6 |
| Amitriptyline | 13 | $142 | $11 |
| Bisoprolol-Hydrochlorothiazide | 14 | $130 | $9 |
| Tramadol | 14 | $117 | $8 |
| Furosemide | 29 | $109 | $4 |
| Sulfamethoxazole-Trimethoprim | 20 | $103 | $5 |
| Temazepam | 16 | $97 | $6 |
| Nortriptyline | 12 | $83 | $7 |
| Ciprofloxacin | 15 | $82 | $5 |
| Prednisone | 12 | $66 | $6 |
2013: 68 drugs
| Aciphex | 12 | $5,747 | $479 |
| Cymbalta | 16 | $5,229 | $327 |
| Advair Diskus | 13 | $5,211 | $401 |
| Vesicare | 17 | $4,949 | $291 |
| Flovent Hfa | 13 | $4,797 | $369 |
| Diovan | 23 | $4,257 | $185 |
| Spiriva | 13 | $4,089 | $315 |
| Atorvastatin | 109 | $4,045 | $37 |
| Lyrica | 11 | $3,894 | $354 |
| Celebrex | 11 | $3,697 | $336 |
| Topamax | 11 | $3,572 | $325 |
| Lidocaine | 12 | $3,471 | $289 |
| Estrace | 14 | $2,989 | $214 |
| Humalog | 19 | $2,875 | $151 |
| Januvia | 11 | $2,836 | $258 |
| Levothyroxine | 152 | $2,225 | $15 |
| Metoprolol | 42 | $2,157 | $51 |
| Premarin | 11 | $2,057 | $187 |
| Asmanex | 11 | $1,654 | $150 |
| Synthroid | 36 | $1,540 | $43 |
| Simvastatin | 90 | $1,218 | $14 |
| Sumatriptan | 22 | $1,115 | $51 |
| Escitalopram | 30 | $1,093 | $36 |
| Montelukast | 15 | $990 | $66 |
| Amlodipine Besylate | 52 | $983 | $19 |
| Fluticasone Propionate | 31 | $949 | $31 |
| Hydrocodone-Acetaminophen | 46 | $922 | $20 |
| Omeprazole | 40 | $792 | $20 |
| Citalopram Hbr | 67 | $717 | $11 |
| Spironolactone | 28 | $676 | $24 |
| Azithromycin | 64 | $666 | $10 |
| Triamterene-Hctz | 32 | $599 | $19 |
| Atenolol | 34 | $578 | $17 |
| Methylphenidate | 20 | $520 | $26 |
| Lisinopril | 61 | $519 | $9 |
| Potassium Chloride | 13 | $510 | $39 |
| Methyclothiazide | 11 | $457 | $42 |
| Losartan-Hydrochlorothiazide | 20 | $454 | $23 |
| Fluoxetine | 13 | $447 | $34 |
| Metformin | 20 | $374 | $19 |
| Nitrofurantoin Mono-Macro | 12 | $343 | $29 |
| Alendronate | 14 | $328 | $23 |
| Topiramate | 18 | $328 | $18 |
| Warfarin | 16 | $321 | $20 |
| Lorazepam | 31 | $308 | $10 |
| Zolpidem | 44 | $308 | $7 |
| Pramipexole Dihydrochloride | 21 | $286 | $14 |
| Alprazolam | 39 | $285 | $7 |
| Quetiapine | 14 | $283 | $20 |
| Metformin Hcl Er | 15 | $278 | $19 |
| Enalapril Maleate | 18 | $275 | $15 |
| Losartan | 13 | $264 | $20 |
| Carisoprodol | 11 | $262 | $24 |
| Pantoprazole | 12 | $256 | $21 |
| Torsemide | 13 | $243 | $19 |
| Clopidogrel | 13 | $201 | $15 |
| Sertraline | 23 | $197 | $9 |
| Metoprolol | 30 | $196 | $7 |
| Bisoprolol-Hydrochlorothiazide | 13 | $182 | $14 |
| Methadone | 29 | $179 | $6 |
| Hydrochlorothiazide | 36 | $154 | $4 |
| Furosemide | 27 | $151 | $6 |
| Gabapentin | 15 | $135 | $9 |
| Ciprofloxacin | 23 | $125 | $5 |
| Trazodone | 18 | $115 | $6 |
| Allopurinol | 13 | $98 | $8 |
| Temazepam | 11 | $94 | $9 |
| Diazepam | 24 | $93 | $4 |
Professional record
- NPI
- 1568495042
- Licence
- CA G64384California G64384: Current · expires 2026-09-30
- Trained
- Warren Alpert Medical School of Brown University, 1987
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0002X (207RH0002X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-08
- NPI last updated
- 2020-06-22
- NPI record certified
- 2020-06-22
This is when the NPI record was last certified, not a medical board exam.